|
Volumn 425, Issue 6954, 2003, Pages 139-141
|
Signalling silenced
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD VESSELS;
ENZYME INHIBITION;
PATIENT TREATMENT;
TUMORS;
BLOOD SUPPLY;
PROTEINS;
TISSUE INHIBITOR OF METALLOPROTEINASE 2;
VASCULOTROPIN;
ENDOTHELIAL CELL GROWTH FACTOR;
FGFR2 PROTEIN, HUMAN;
FIBROBLAST GROWTH FACTOR RECEPTOR;
FIBROBLAST GROWTH FACTOR RECEPTOR 2;
LYMPHOKINE;
MATRIX METALLOPROTEINASE;
PROTEIN TYROSINE KINASE;
SIGNAL PEPTIDE;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR;
BLOOD;
PROTEIN;
SIGNALING;
ANGIOGENESIS;
CANCER;
CELL MIGRATION;
CELL PROLIFERATION;
ENDOTHELIUM CELL;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
SHORT SURVEY;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFECT;
GENETICS;
HUMAN;
METABOLISM;
NEOPLASM;
SIGNAL TRANSDUCTION;
VASCULARIZATION;
ENDOTHELIAL GROWTH FACTORS;
HUMANS;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
LYMPHOKINES;
MATRIX METALLOPROTEINASES;
NEOPLASMS;
NEOVASCULARIZATION, PHYSIOLOGIC;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2;
RECEPTORS, FIBROBLAST GROWTH FACTOR;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
SIGNAL TRANSDUCTION;
TISSUE INHIBITOR OF METALLOPROTEINASE-2;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 0141704259
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/425139a Document Type: Short Survey |
Times cited : (7)
|
References (15)
|